Cargando…
Nuclear Osteopontin Is a Marker of Advanced Heart Failure and Cardiac Allograft Vasculopathy: Evidence From Transplant and Retransplant Hearts
BACKGROUND: Heart transplant is the gold standard therapy for patients with advanced heart failure. Over 5,500 heart transplants are performed every year worldwide. Cardiac allograft vasculopathy (CAV) is a common complication post-heart transplant which reduces survival and often necessitates heart...
Autores principales: | Irion, Camila Iansen, Dunkley, Julian C., John-Williams, Krista, Condor Capcha, José Manuel, Shehadeh, Serene A., Pinto, Andre, Loebe, Matthias, Webster, Keith A., Brozzi, Nicolas A., Shehadeh, Lina A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438570/ https://www.ncbi.nlm.nih.gov/pubmed/32903540 http://dx.doi.org/10.3389/fphys.2020.00928 |
Ejemplares similares
-
Osteopontin Expression in Cardiomyocytes Is Increased in Pediatric Patients With Sepsis or Pneumonia
por: Irion, Camila Iansen, et al.
Publicado: (2018) -
Mouse Model of Heart Failure With Preserved Ejection Fraction Driven by Hyperlipidemia and Enhanced Cardiac Low‐Density Lipoprotein Receptor Expression
por: Williams, Monique, et al.
Publicado: (2022) -
Peptide-Functionalized Dendrimer Nanocarriers for Targeted Microdystrophin Gene Delivery
por: Hersh, Jessica, et al.
Publicado: (2021) -
Heart Retransplant Recipients Have Better Survival With Concurrent Kidney Transplant Than With Heart Retransplant Alone
por: Savla, Jill, et al.
Publicado: (2015) -
S2 Heart Sound Detects Aortic Valve Calcification Independent of Hemodynamic Changes in Mice
por: Dargam, Valentina, et al.
Publicado: (2022)